home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Good Laboratory Practices Seminar

 
  August 17, 2007  
     
 


SPI USA, Inc., San Francisco, CA
September 13 and 14


* Introduction to the FDA
1. FDA Overview of the Biopharmaceutical Industry
2. FDA Organization as it pertains to the Biopharm Industry
3. Overview and History of 21 CFR Part 58
Group Discussion: Current GLP responsibilities and experiences of class participants


* GLP vs. GMP, GCP
1. GMP application
2. GCP application
3. GLP's role in the Biopharm Industry
1. GLP in the Drug Discovery Process
2. Preclinical studies
4. Drug commercialization timeline with GLP application shown

* Overview of the science of GLP
1. Categories and examples of preclinical tests
2. Preclinical Safety Studies - cell culture and animal studies

* GLP Laboratory Organizatio & Function
1. Personnel
2. Qualifications
3. Study Director
4. Quality Assurance Unit
5. Facility Manager

* GLP Facilities - Design and Qualification
1. Receiving and Storage
2. Laboratories
3. Animal Rooms
4. Office space - secured/safe
5. Archives


* GLP Documentation - general overview of documentation
1. Documentation Requirements in GLP Operations
1. Study protocol
2. Protocol amendments
2. SOPs vs. protocols - definitions
3. Laboratory Documentation
1. Data and Reporting
2. Raw Data
3. Electronic Data
4. GLP Study Reports
1. Required components
2. Report amendments
5. Responsibilities
6. GLP archiving

* Laboratory Deviations and Out of Specification Results
1. Definitions
2. Required Actions
3. Documentation
4. Changes and Approvals
5. Comparison of documentation to chain of custody

* Testing/Laboratory SOPs
1. SOP format
2. SOP dos and dont's
3. Deviations


* Laboratory Equipment
1. Preventive maintenance
2. Calibration
3. Cleaning


* Audits
1. What to expect/how to prepare
2. Behavior during an audit
3. Follow-up actions
4. Most common deficiencies in GLP inspections
Exercise: Review of FDA 483 Citations of GLP Facilities

* Summary and Questions

 
 
Organized by: SPI USA, Inc.
Invited Speakers: Alison Demarest
 
Deadline for Abstracts: 2007-09-01
 
Registration: Cost: $1550 per enrollment
Advance Registration Cost: $1400 per enrollment (until 30 days prior to seminar date)
Group Rate: $1500 per enrollment
Government/Academic Rate: $1250 per enrollment
E-mail: ngoncalves@usaspi.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.